NCT02287181View on ClinicalTrials.gov

A Phase IV Study Investigating the Effects of Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Induction of Anaesthesia
Interventions
DRUG

Remifentanil

short acting opiate

DRUG

Propofol

hypnotic drug

OTHER

Bispectral index

electroencephalograph

Trial Locations (1)

Unknown

Queen Mary Hospital, Pok Fu Lam

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02287181 - A Phase IV Study Investigating the Effects of Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes | Biotech Hunter | Biotech Hunter